Portal de Periódicos da CAPES

Influence of Anxiety and Depression on Opioid Use Following Lumbar Spine Fusion

2023; Lippincott Williams & Wilkins; Linguagem: Inglês

10.1097/bsd.0000000000001505

2380-0194

Heeren Makanji, Matthew J. Solomito, Regina O. Kostyun, Sean Esmende,

Musculoskeletal pain and rehabilitation

Study Design: Retrospective database. Objective: The purpose of this study was to understand how a mental health disorder, specifically anxiety and depression, influences a patient’s postoperative opioid needs following single-level lumbar spine fusion. Summary of Background Data: Patients with spine pathology commonly demonstrate symptoms of an active psychiatric disorder. Mental health significantly influences how a patient perceives pain and a patient’s opioid pain control needs after surgery. Materials and Methods: The Pearldiver Patient Claims Database was used to identify patients undergoing single-level posterior spine fusion within the United States between 2010 and 2020. Patients were placed into 1 of 4 groups: those with a diagnosis of depression, those with a diagnosis of anxiety, those with a diagnosis of both anxiety and depression, and a control group. χ 2 tests were used to assess differences in the number of patients filling initial and additional opioid prescriptions for up to 90 days following their fusion. Results: The control group filled significantly more initial opioid prescriptions within the first 90 days following their spine fusion ( P <0.001). However, there was no difference among the study groups in regard to the additional need for prescriptions. Conclusion: Patients with mental health diagnoses may present as complex patients to spine surgeons; however, this study suggests they do not require additional opioid pain control following a single-level lumbar fusion.